Morgan Stanley lowered the firm’s price target on Iqvia (IQV) to $225 from $240 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210
- IQVIA: Buy Rating Reiterated on Solid Growth and Valuation, $240 Price Target Unchanged
- IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook
- IQVIA Holdings Earnings Call Highlights Growth And AI
- Iqvia reports Q1 adjusted EPS $2.90, consensus $2.82